Observation of changes in ocular findings before and after the use of the IL-4 and 13 antibody preparation dupilumab
Not Applicable
Recruiting
- Conditions
- Atopic dermatitis, bronchial asthma, sinusitis, and ocular disorders
- Registration Number
- JPRN-UMIN000038675
- Lead Sponsor
- Keio University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who have refused to provide clinical information to this study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method